Ivantis HYDRUS II Glaucoma Study Met Primary Endpoint In a Randomized Controlled Trial at 2 Years
- 21 October 2014
Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.
© 2021- edbi. All rights reserved.